WallStreetZenWallStreetZen

NASDAQ: GOVX
Geovax Labs Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GOVX

Based on 1 analyst offering 12 month price targets for Geovax Labs Inc

Min Forecast
$1.00-51.46%
Avg Forecast
$1.00-51.46%
Max Forecast
$1.00-51.46%

Should I buy or sell GOVX stock?

Based on 1 analyst offering ratings for Geovax Labs Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GOVX stock forecasts and price targets.

GOVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-16

1 of 1

Forecast return on equity

Is GOVX forecast to generate an efficient return?

Company
56,681.31%
Industry
28.82%
Market
143.77%
GOVX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GOVX forecast to generate an efficient return on assets?

Company
9,384.13%
Industry
-0.66%
GOVX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GOVX earnings per share forecast

What is GOVX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$33.92
Avg 2 year Forecast
-$22.44
Avg 3 year Forecast
$80.58

GOVX revenue forecast

What is GOVX's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$211.7M

GOVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GOVX$2.06$1.00-51.46%Hold
ASBP$5.49N/AN/A
XBIO$3.15N/AN/A
PCSA$2.56N/AN/A
EVGN$0.71N/AN/A
View Top Biotech Stocks

Geovax Labs Stock Forecast FAQ

Is Geovax Labs Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GOVX) stock is to Hold GOVX stock.

Out of 1 analyst, 0 (0%) are recommending GOVX as a Strong Buy, 0 (0%) are recommending GOVX as a Buy, 1 (100%) are recommending GOVX as a Hold, 0 (0%) are recommending GOVX as a Sell, and 0 (0%) are recommending GOVX as a Strong Sell.

If you're new to stock investing, here's how to buy Geovax Labs stock.

What is GOVX's earnings growth forecast for 2026-2028?

(NASDAQ: GOVX) Geovax Labs's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 66.57%.

Geovax Labs's earnings in 2026 is -$21,369,041.On average, 4 Wall Street analysts forecast GOVX's earnings for 2026 to be -$117,795,613, with the lowest GOVX earnings forecast at -$150,617,920, and the highest GOVX earnings forecast at -$81,144,037. On average, 3 Wall Street analysts forecast GOVX's earnings for 2027 to be -$77,939,954, with the lowest GOVX earnings forecast at -$74,883,486, and the highest GOVX earnings forecast at -$80,232,306.

In 2028, GOVX is forecast to generate $279,875,291 in earnings, with the lowest earnings forecast at $268,899,789 and the highest earnings forecast at $288,106,917.

What is GOVX's revenue growth forecast for 2026-2028?

(NASDAQ: GOVX) Geovax Labs's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.36%.

Geovax Labs's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast GOVX's revenue for 2026 to be $0, with the lowest GOVX revenue forecast at $0, and the highest GOVX revenue forecast at $0. On average, 3 Wall Street analysts forecast GOVX's revenue for 2027 to be $0, with the lowest GOVX revenue forecast at $0, and the highest GOVX revenue forecast at $0.

In 2028, GOVX is forecast to generate $735,393,340 in revenue, with the lowest revenue forecast at $2,767,285 and the highest revenue forecast at $1,511,076,496.

What is GOVX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: GOVX) forecast ROA is 9,384.13%, which is higher than the forecast US Biotechnology industry average of -0.66%.

What is GOVX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GOVX price target, the average GOVX price target is $1.00, with the highest GOVX stock price forecast at $1.00 and the lowest GOVX stock price forecast at $1.00.

The Wall Street analyst predicted that Geovax Labs's share price could fall to $1.00 by Apr 16, 2027. The average Geovax Labs stock price prediction forecasts a potential downside of 51.46% from the current GOVX share price of $2.06.

What is GOVX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GOVX) Geovax Labs's current Earnings Per Share (EPS) is -$17.42. On average, analysts forecast that GOVX's EPS will be -$33.92 for 2026, with the lowest EPS forecast at -$43.37, and the highest EPS forecast at -$23.36. On average, analysts forecast that GOVX's EPS will be -$22.44 for 2027, with the lowest EPS forecast at -$21.56, and the highest EPS forecast at -$23.10. In 2028, GOVX's EPS is forecast to hit $80.58 (min: $77.42, max: $82.95).

What is GOVX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: GOVX) forecast ROE is 56,681.31%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.